Navamedic ASA: Notification of major shareholding and mandatory notification of trade
Oslo, 12 March 2024 - Ingerø Reiten Investment Company AS ("IRIC") has today sold all of its shares in the Nordic pharmaceutical company Navamedic ASA. The shares were sold for 32 kroner per share, for total gross proceeds of approximately NOK 95 million, or about 2.7 times the amount invested. IRIC has been Navamedic's principal owner and strategic partner since 2019. IRIC will use part of the proceeds to strengthen its balance sheet by paying off debt. "For IRIC this was the right time to sell. Navamedic is a first-class company, but as a large, strategic investor, it is also important